Published in J Hum Hypertens on September 01, 1995
DNA-damaging agents stimulate gene expression at specific loci in Escherichia coli. Proc Natl Acad Sci U S A (1980) 7.87
Inducibility of a gene product required for UV and chemical mutagenesis in Escherichia coli. Proc Natl Acad Sci U S A (1981) 4.09
Effect of renal-artery stenting on progression of renovascular renal failure. Lancet (1997) 3.89
Cloned fragments of the plasmid ColV,I-K94 specifying virulence and serum resistance. Nature (1979) 3.18
Expression of the E. coli uvrA gene is inducible. Nature (1981) 3.18
Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int (2007) 3.17
A calcium-channel homologue required for adaptation to dopamine and serotonin in Caenorhabditis elegans. Nature (1995) 2.61
Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest (1998) 2.36
Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J (1970) 2.33
Better blood pressure control: how to combine drugs. J Hum Hypertens (2003) 2.19
Role of a new Rho family member in cell migration and axon guidance in C. elegans. Cell (1997) 2.18
Serotonin-deficient mutants and male mating behavior in the nematode Caenorhabditis elegans. J Neurosci (1993) 2.03
Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension (2001) 1.97
The estimation of renin in human plasma. Biochem J (1964) 1.85
Plasma Renin Concentration in Human Hypertension-III: Renin in Relation to Complications of Hypertension. Br Med J (1966) 1.83
Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab (1998) 1.80
Weight reduction in a blood pressure clinic. Br Med J (1978) 1.67
Regulation of damage-inducible genes in Escherichia coli. J Mol Biol (1982) 1.63
Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther (1994) 1.63
Families of patients with premature coronary heart disease: an obvious but neglected target for primary prevention. BMJ (2007) 1.63
Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture. Hypertension (1980) 1.60
Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation (2000) 1.54
Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology (2000) 1.54
Diuretics: mechanism of action and clinical application. Drugs (1975) 1.54
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia (1997) 1.49
Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide. Clin Pharmacol Ther (1974) 1.47
Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology. Am J Physiol Endocrinol Metab (2004) 1.47
Renin and angiotensin. A survey of some aspects. Postgrad Med J (1966) 1.45
Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension (1999) 1.44
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol (2001) 1.41
Colicin V production by clinical isolates of Escherichia coli. Infect Immun (1981) 1.41
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet (1979) 1.37
Concurrent estimation of total body and exchangeable body sodium in hypertension. Clin Sci Mol Med (1978) 1.34
Endothelial function in hypertension: the role of superoxide anion. Hypertension (1999) 1.33
Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration. Br Med J (1975) 1.32
Genes affecting sensitivity to serotonin in Caenorhabditis elegans. Genetics (1996) 1.31
Simultaneous measurement of total exchangeable potassium and sodium using 43 K and 24 Na. Metabolism (1973) 1.28
Lack of tissue glucocorticoid reactivation in 11beta -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proc Natl Acad Sci U S A (2001) 1.20
Plasma renin concentration in human hypertension . II. Renin in relation to aetiology. Br Med J (1965) 1.19
Sodium and potassium in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.18
Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity? Lancet (1975) 1.18
Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet (1997) 1.18
Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol (1997) 1.17
Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension (1995) 1.17
Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol (2000) 1.13
Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes (1998) 1.11
Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation (1998) 1.11
Plasma-renin and aldosterone secretion in hypertensive patients with renal or renal artery lesions. Lancet (1965) 1.10
Analysis of mRNA synthesis following induction of the Escherichia coli SOS system. J Mol Biol (1984) 1.09
Enalapril (MK421) in the treatment of hypertension with renal artery stenosis. J Hypertens Suppl (1983) 1.09
Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus. Mol Ther (2001) 1.08
The role of lin-22, a hairy/enhancer of split homolog, in patterning the peripheral nervous system of C. elegans. Development (1997) 1.06
Blood pressure in genetically hypertensive rats. Influence of the Y chromosome. Hypertension (1995) 1.05
Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens (2001) 1.04
Cellular aspects of vascular remodeling in hypertension revealed by confocal microscopy. Hypertension (1997) 1.04
Altered vascular contractility in adult female rats with hypertension programmed by prenatal glucocorticoid exposure. J Endocrinol (2006) 1.04
The role of small, dense low density lipoprotein (LDL): a new look. Int J Cardiol (2000) 1.02
The effect of acute haemorrhage in the dog and man on plasma-renin concentration. J Physiol (1966) 1.02
Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats. J Endocrinol (2000) 1.02
Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure. Lancet (1973) 1.01
Brain aromatase expression after experimental stroke: topography and time course. J Steroid Biochem Mol Biol (2005) 1.01
Quantitative trait loci in genetically hypertensive rats. Possible sex specificity. Hypertension (1996) 1.01
A Golgi study of mouse hippocampal CA1 pyramidal neurons following perinatal ethanol exposure. Neurosci Lett (1981) 1.00
Serial estimation of plasma renin concentration during pregnancy and after parturition. J Endocrinol (1966) 0.99
Plasma concentration of renin in a patient with Conn's syndrome with fibrinoid lesions of the renal arterioles: the effect of treatment with spironolactone. J Endocrinol (1965) 0.99
Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. J Hypertens (1987) 0.98
Characterization of the microglial response to cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension (2001) 0.98
Genetic and gender influences on sensitivity to focal cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension (1999) 0.98
Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11beta-hydroxysteroid dehydrogenase. Circulation (2001) 0.98
Control of cell proliferation in the rat adrenal gland in vivo by the renin-angiotensin system. Am J Physiol (1996) 0.98
Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy. Pharm Res (1997) 0.97
Alteration of a single tryptophan residue of the cellulose-binding domain blocks secretion of the Erwinia chrysanthemi Cel5 cellulase (ex-EGZ) via the type II system. J Mol Biol (2000) 0.97
Enalapril in the treatment of hypertension with renal artery stenosis. Br Med J (Clin Res Ed) (1983) 0.97
Intravenous labetalol in hypertensive emergency. Lancet (1979) 0.97
The metabolism of clonidine and related imidazoline derivatives in rat liver [proceedings]. Br J Pharmacol (1978) 0.96
Isolation of the gene encoding an immunodominant membrane protein of the apple proliferation phytoplasma, and expression and characterization of the gene product. Microbiology (1999) 0.95
Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Ther (2002) 0.95
Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess. Lancet (1974) 0.94
Plasma-renin concentration in hypertensive disease of pregnancy. Lancet (1965) 0.94
Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension. J Hypertens (1992) 0.94
Control of adrenal cell proliferation by AT1 receptors in response to angiotensin II and low-sodium diet. Am J Physiol (1999) 0.94
Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes (2000) 0.94
Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation (1996) 0.94
Pregnancy complicated by Cushing's syndrome: potential hazard of metyrapone therapy. Case report. Br J Obstet Gynaecol (1985) 0.94
The use of scintigraphy to provide "proof of concept" for novel polysaccharide preparations designed for colonic drug delivery. Pharm Res (1997) 0.94
Cellular changes induced by chronic nitric oxide inhibition in intact rat basilar arteries revealed by confocal microscopy. J Hypertens (1997) 0.93
Amiloride in the treatment of primary hyperaldosteronism and essential hypertension. Clin Endocrinol (Oxf) (1977) 0.92
Applicability of a "speed" congenic strategy to dissect blood pressure quantitative trait loci on rat chromosome 2. Hypertension (2000) 0.92
Pathophysiology of the vasculature in hypertension. Hypertension (1991) 0.92
Cerebral small vessel endothelial structural changes predate hypertension in stroke-prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5- to 21-week-old rats. Neuropathol Appl Neurobiol (2011) 0.92
Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease. Kidney Int (1991) 0.92
Falsely high plasma potassium values in patients with hyperaldosteronism. Br Med J (1970) 0.91
Improved system for measuring systolic blood pressure in the conscious rat. Med Biol Eng Comput (1994) 0.91
Hypertension in chronic renal failure. An abnormal relation between sodium and the renin-angiotensin system. Am J Med (1973) 0.91
Plasma renin concentration in the hypertensive diseases of pregnancy. J Obstet Gynaecol Br Commonw (1966) 0.91
Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis. Br Med J (Clin Res Ed) (1982) 0.91
Confocal microscopic characterization of a lesion in a cerebral vessel of the stroke-prone spontaneously hypertensive rat. Stroke (1996) 0.91
Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clin Sci (Lond) (1982) 0.90